Low-dose dapsone, co-trimoxazole, and survival in Pneumocystis carinii primary prophylaxis

AIDS. 1996 Aug;10(9):1046-7. doi: 10.1097/00002030-199610090-00020.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • AIDS-Related Opportunistic Infections / drug therapy*
  • Anti-Infective Agents / adverse effects
  • Anti-Infective Agents / therapeutic use*
  • Dapsone / adverse effects
  • Dapsone / therapeutic use*
  • Drug Therapy, Combination
  • Humans
  • Pneumonia, Pneumocystis / drug therapy*
  • Pneumonia, Pneumocystis / mortality
  • Trimethoprim, Sulfamethoxazole Drug Combination / adverse effects
  • Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use*

Substances

  • Anti-Infective Agents
  • Trimethoprim, Sulfamethoxazole Drug Combination
  • Dapsone